GSA Capital Partners’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
Other funds holding GPCR
BBA
GSA Capital Partners's GPCR Position: Q3 2026 in Review
GSA Capital Partners sold out of Structure Therapeutics (GPCR) in Q3 2026, closing a stake of 28,665 shares — an estimated $1.54M sold.
GSA Capital Partners first reported a position in GPCR in Q3 2024 and held it in 4 quarters. The position peaked at $1.54M in Q2 2026. 169 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.
- GSA Capital Partners reported no remaining Structure Therapeutics position as of Q3 2026 after selling out during the quarter.
- GSA Capital Partners sold 28,665 Structure Therapeutics shares in Q3 2026, an estimated $1.54M.
- GSA Capital Partners first reported a position in Structure Therapeutics in Q3 2024 and held it in 4 quarters.
- GSA Capital Partners's Structure Therapeutics position peaked at $1.54M in Q2 2026.
- 169 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.
Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.